ETC-159

CAS : 1638250-96-0

Ref. 3D-NQC25096

Informations sur le produit

• Nom: ETC-159
• CAS: 1638250-96-0

Description

ETC-159 is a monoclonal antibody that binds to and inhibits the function of β-catenin. It is an orally administered drug that has been shown to be effective for the treatment of solid tumours, such as colorectal cancer. ETC-159 blocks the cell signaling pathways mediated by β-catenin, which may lead to tumor suppression. This drug also has the ability to inhibit TNF-α and suppressor genes in cancer cells, which are involved in tumor growth. The chemical structure of this molecule includes a pan-PI3K inhibitor with a potential application in inhibiting cancers that are not responsive to conventional therapy.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 391.38 g/mol
• Formule: C₁₉H₁₇N₇O₃
• Degré de pureté: Min. 95%